b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">\n        <PMID Version="1">31616178</PMID>\n        <DateRevised>\n            <Year>2019</Year>\n            <Month>10</Month>\n            <Day>23</Day>\n        </DateRevised>\n        <Article PubModel="Electronic-eCollection">\n            <Journal>\n                <ISSN IssnType="Print">1179-1322</ISSN>\n                <JournalIssue CitedMedium="Print">\n                    <Volume>11</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Cancer management and research</Title>\n                <ISOAbbreviation>Cancer Manag Res</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>The Hedgehog signal transducer <i>Smoothened</i> and microRNA-326: pathogenesis and regulation of drug resistance in pediatric B-cell acute lymphoblastic leukemia.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>7621-7630</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.2147/CMAR.S214405</ELocationID>\n            <Abstract>\n                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">Multidrug resistance (MDR) and the subsequent disease relapse are the major causes of childhood acute lymphoblastic leukemia (ALL) related death. The Hedgehog (Hh) signaling pathway can contribute to cancer MDR. In the current study, <i>Smoothened</i> (<i>Smo</i>) was selected as the experimental target due to its importance in the Hh pathway in order to evaluate its probable role in pediatric B-ALL drug resistance.</AbstractText>\n                <AbstractText Label="Patients and methods" NlmCategory="UNASSIGNED">The study included 27 pediatric B-ALL and 16 control bone marrow samples. Quantitative RT-PCR was used to investigate the expression levels of <i>Smo</i> and miR-326 as the key players of the Hh pathway. Western blot analysis was performed. The presence of minimal residual disease was studied using PCR-SSCP. The association between Smo expression and drug resistance was analyzed statistically.</AbstractText>\n                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Results showed a significant increase in the <i>Smo</i> expression levels in drug-resistant patients in comparison with drug-sensitive children with B-ALL (<i>P</i>=0.0128, AUC=0.82). A considerable negative association between miR-326 and <i>Smo</i> expression levels was identified (<i>r</i>=-0.624, <i>P</i>=0.002). A binomial test confirmed the regulatory role of miR-326 on the translational repression of <i>Smo</i> (<i>P</i>=0.031). Statistics showed no association between <i>Smo</i> and <i>ABCA2</i> expression levels. However, a significant positive correlation was observed between the <i>Smo</i> and <i>ABCA3</i> transcripts in the resistant ALL children (<i>r</i>=0.607, <i>P</i>=0.016).</AbstractText>\n                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Data revealed the possible oncogenic impact of Smo on leukemogenesis and drug resistance in pediatric B-ALL. Upregulation of <i>Smo</i> was introduced, for the first time, as a prognostic factor for drug resistance in childhood B-ALL. To the best of our knowledge, this is the first study that shows a positive correlation between <i>Smo</i> and <i>ABCA3</i> expression levels in pediatric B-ALL, explaining a possible mechanism for the development of drug resistance in this cancer. Moreover, the current project revealed a negative modulatory effect of miR-326 on the expression levels of <i>Smo</i>.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 Sheybani et al.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Sheybani</LastName>\n                    <ForeName>Zahra</ForeName>\n                    <Initials>Z</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Rahgozar</LastName>\n                    <ForeName>Soheila</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ghodousi</LastName>\n                    <ForeName>Elaheh Sadat</ForeName>\n                    <Initials>ES</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Biology, Faculty of Science, University of Isfahan, Isfahan, Iran.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>12</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>New Zealand</Country>\n            <MedlineTA>Cancer Manag Res</MedlineTA>\n            <NlmUniqueID>101512700</NlmUniqueID>\n            <ISSNLinking>1179-1322</ISSNLinking>\n        </MedlineJournalInfo>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">ABC transporter</Keyword>\n            <Keyword MajorTopicYN="N">Hh pathway</Keyword>\n            <Keyword MajorTopicYN="N">Smo</Keyword>\n            <Keyword MajorTopicYN="N">miR-326</Keyword>\n        </KeywordList>\n        <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>07</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>17</Day>\n                <Hour>6</Hour>\n                <Minute>1</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>epublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31616178</ArticleId>\n            <ArticleId IdType="doi">10.2147/CMAR.S214405</ArticleId>\n            <ArticleId IdType="pii">214405</ArticleId>\n            <ArticleId IdType="pmc">PMC6698603</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Cell Physiol. 2018 Aug;233(8):5726-5735</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29380372</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Anticancer Res. 2014 Nov;34(11):6339-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25368233</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Gene. 2019 Apr 15;692:35-43</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30639603</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Tumour Biol. 2017 Jul;39(7):1010428317715546</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28675107</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2008 Sep 9;14(3):238-49</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18772113</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Physiol. 2018 Aug;233(8):5642-5654</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29154447</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2011 Dec 8;30(49):4874-86</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21625222</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res. 2011 Jun 10;13(3):211</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21672282</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Lett. 2015 Dec 1;369(1):124-33</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26276718</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Cell Biochem. 2018 Jul;119(7):6024-6032</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29630744</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Biol. 2007 Jan 23;17(2):165-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17196391</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancers (Basel). 2015 Aug 11;7(3):1554-85</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26270676</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Cell. 2014 Feb 10;25(2):139-51</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24525231</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Commun. 2015 Mar 19;6:6604</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25790293</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Cell Biol. 2013 Apr;15(4):338-44</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23548926</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2018 Jan 1;142(1):109-120</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28905994</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neuro Oncol. 2015 Feb;17(2):243-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25173582</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2014 Jul 3;511(7507):90-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24870236</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2007 Aug 16;26(38):5674-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17353904</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Onco Targets Ther. 2017 Jul 10;10:3373-3380</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28744141</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Blood. 2012 Dec 13;120(25):5002-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22821765</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2018 Jan 25;553(7689):511-514</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29342136</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Bone Marrow Res. 2013;2013:269107</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24416592</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nature. 2009 Apr 9;458(7239):776-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19169242</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncogene. 2015 Jul;34(28):3617-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25263438</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Chem Biol. 2017 Mar 16;24(3):252-280</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28286127</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Crit Rev Oncol Hematol. 2018 Jun;126:100-111</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29759551</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer. 2017 Jul 1;123(13):2398-2403</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28328172</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Biol Ther. 2014 Jan;15(1):35-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24145140</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Cancer. 2013 Aug 1;133(3):579-89</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23341351</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>PLoS One. 2010 Dec 28;5(12):e15262</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21203400</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Bosn J Basic Med Sci. 2018 Feb 20;18(1):8-20</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29274272</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncol Rep. 2017 Feb;37(2):1261-1269</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27959416</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Oncologist. 2016 Oct;21(10):1218-1229</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27511905</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cancer Biol Ther. 2018 Apr 3;19(4):260-270</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27819521</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14134-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16968775</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'